Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
Abstract Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was t...
Saved in:
Main Authors: | Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b7713b8a6ec64937b394d31d9f097f2f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
by: Theresia Monica Rahardjo, et al.
Published: (2021) -
Convalescent Plasma for the Treatment of Severe COVID-19
by: Franchini M, et al.
Published: (2021) -
Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review
by: Mariela Irabien-Zúñiga, et al.
Published: (2021) -
SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
by: Hennie Husniah, et al.
Published: (2021) -
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
by: Cathrine Axfors, et al.
Published: (2021)